A lower proportion of encephalopathy (37.1 vs 56.1%, p < 0.001), hypervolemia (24.5 vs 56.1%, p < 0.001) and higher proportion of AVF (30.8 vs 2.8%, p < 0.001), Diuretic (65.7 vs 36.4, p < 0.001), ACEI (67.8 vs 38.3, p < 0.001), ßeta blocker (21.0 vs 10.3, p < 0.001), EPO (64.3 vs 38.3, p < 0.001) were also observed in survivors patients in comparison to those who have died. The gene discussed is EPO; the disease is Encephalopathy.